School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, United Kingdom; School of Pharmacy, Middle East University, Amman 11831, Jordan.
School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, United Kingdom; Faculty of Pharmacy, Aleppo University, Aleppo, Syria; R&D Department-Formulations, Norbrook Labs, Station Works, Newry BT35 6QQ, United Kingdom.
Eur J Pharm Biopharm. 2022 Oct;179:105-117. doi: 10.1016/j.ejpb.2022.08.022. Epub 2022 Sep 5.
Basal cell carcinoma (BCC) is the most common form of skin cancer and responsible for most of the cancer related morbidities and pose a significant public health concern worldwide. Surgery treatment modality is able to clear the BCC, yet it mostly leads to scar formation. Plasmonic photothermal therapy (PPTT) which involves using gold nanostructures and near-infrared (NIR) light to kill the BCC cells by local heating is associated with excellent tissue preservation and healing without scarring. Parenteral administration of such gold nanostructures suffers from off-target delivery and side effects. Delivering such phototherapeutics directly to the BCC proved to be an attractive alternative route of administration yet encountered with penetration limitations due to the stratum corneum (SC) fierce barrier. In the current study, we developed and optimised a novel NIR light-responsive hydrogel-forming long needle (HFLN) loaded with Gold nanorods (GNRs) as a potential plasmonic photothermal device for localised treatment of nodular BCC. The HFLN was prepared from Gantrez® S-97 and poly(ethylene glycol) (PEG) 200 Da and characterized in terms of swelling, insertion and mechanical properties. GNRs were synthesised and tunned using seed-mediated growth method. The integrated devices developed could revolutionise BCC treatment benefiting both patients and healthcare providers.
基底细胞癌 (BCC) 是最常见的皮肤癌,也是导致大多数癌症相关发病率的主要原因,在全球范围内引起了重大的公共卫生关注。手术治疗方法能够清除 BCC,但它主要会导致疤痕形成。等离子体光热疗法 (PPTT) 涉及使用金纳米结构和近红外 (NIR) 光通过局部加热来杀死 BCC 细胞,它与出色的组织保存和无疤痕愈合相关。这种金纳米结构的注射给药会遭受靶向传递和副作用的困扰。将这种光疗药物直接递送到 BCC 被证明是一种有吸引力的替代给药途径,但由于角质层 (SC) 的强烈屏障,存在穿透限制。在当前的研究中,我们开发并优化了一种新型的近红外光响应水凝胶形成长针 (HFLN),负载金纳米棒 (GNRs),作为一种潜在的等离子体光热装置,用于局部治疗结节性 BCC。HFLN 由 Gantrez® S-97 和聚乙二醇 (PEG) 200 Da 制备,并在溶胀、插入和机械性能方面进行了表征。GNRs 是使用种子介导的生长方法合成和调谐的。开发的集成设备可以彻底改变 BCC 治疗,使患者和医疗保健提供者受益。